On September 24, 2026, the strategic cooperation signing ceremony between Sichuan Gonwing Biotechnology Co., Ltd. and Sichuan Zhenheng Technology Co., Ltd. was successfully held in Chengdu.
2026 年 9 月 24 日，四川珙辉生物技术有限公司与四川真衡科技有限公司战略合作签约仪式于成都顺利举行。
本次签约标志着珙辉生物与真衡科技正式确立深度战略合作伙伴关系。
四川珙辉生物立足于体外诊断领域，专注于智能形态学分析设备、配套试剂耗材的研发与产品创新；四川真衡科技在医疗产业市场运营、行业资源布局方面积累深厚。 立足于本次战略合作，双方将充分发挥各自核心优势，实现研发端与市场端的协同赋能。依托资源互补，共同探索业务新模式，合力拓展产业发展空间，携手挖掘体外诊断行业的市场机遇。
道阻且长，行则将至。 未来，双方将持续深化多维度的协同协作，凝心聚力，携手并肩，在体外诊断赛道携手前行，共绘行业发展的崭新蓝图。
On September 24, 2026, the strategic cooperation signing ceremony between Sichuan Gonwing Biotechnology Co., Ltd. and Sichuan Zhenheng Technology Co., Ltd. was successfully held in Chengdu.
This signing marks the official establishment of an in‑depth strategic partnership between Gonwing Biology and Zhenheng Technology.
Rooted in the in‑vitro diagnostic industry, Sichuan Gonwing Biotechnology focuses on R&D and product innovation of intelligent morphological analysis instruments as well as supporting reagents and consumables. Sichuan Zhenheng Technology has rich experience in medical market operation and industrial resource deployment.
Based on this strategic cooperation, both parties will give full play to their respective core strengths to realize collaborative empowerment between R&D and marketing. Leveraging complementary resources, the two sides will jointly explore new business models, expand industrial development space, and seize market opportunities within the IVD (In‑Vitro Diagnosis) sector.
The journey ahead may be long, yet progress will surely be made. Going forward, the two enterprises will continue to deepen multi‑dimensional collaboration. United hand‑in‑hand, they will forge ahead on the IVD track and jointly draw a brand‑new blueprint for the development of the industry.
